Lung Association Awards Minnesota Researcher Grant to Study New Treatments for Lung Disease

A Minnesota doctor has been awarded a grant from the American Lung Association Research Institute for his research project. Nicholas Goplen, PhD at the Mayo Clinic was awarded the Emerging Respiratory Pathogen Award.

Lung research is critical in Minnesota because more than 770,000 residents are living with lung disease, and the Lung Association is honored to welcome Dr. Goplen to our elite American Lung Association Research Institute team.

His project focuses on abnormal immune regulation in post-viral pulmonary fibrosis. Different respiratory viruses that cause severe lung damage and pandemics, can lead to scarring and dysfunction of the lung lasting months or even years. He will determine how CD8+T cell functions required to sterilize the lung, interfere with specialized cells involved in its regeneration. Many “long COVID” symptoms are associated with the accumulation of T cells and Dr. Goplen anticipates his research will lead to more effective therapeutics that can be applied to emerging respiratory pathogens.

In the past year, the American Lung Association Research Institute has announced a total research investment of $22 million, making it one of the largest programs in the country focused on lung health. The Lung Association funded 139 research grants, including the Airways Clinical Research Centers (ACRC), and strategic research partnerships focused on finding ways to identify, treat and cure lung disease.

This year, the American Lung Association is celebrating 120 years of funding lifesaving research. Lung Association researchers have achieved major milestones, including helping end the devastation of tuberculosis in this country, saving millions of lives of premature babies with respiratory distress syndrome (RDS), supporting research on COVID-19 and much more.

Awards were given different categories addressing many aspects of lung disease; American Lung Association/AAAAI Allergic Respiratory Diseases Award, American Lung Association/ATS/CHEST Foundation Respiratory Health Equity Research Award, Catalyst Award, Emerging Respiratory Diseases (formerly, COVID-19 Respiratory Virus Research Award), Public Health & Public Policy Research Award, Hastings Innovation Award for Interstitial Lung Disease, Dalsemer Interstitial Lung Disease Award, Innovation Award, and the Lung Cancer Discovery Award.

Research projects funded by the Lung Association are carefully selected through rigorous scientific peer review and awardees represent the investigation of a wide range of complex issues related to lung health.

The Lung Association is currently accepting applications for its 2025-2026 research awards and grants cycle. For more information about the active research funding opportunities, visit Lung.org/awards. For more information about the new grant awardees and the entire American Lung Association Research Team, visit Lung.org/research-team.

Media Resources

• Media b-roll is available here: Broll: ALA Research Team.mp4 | Powered by Box
• American Lung Association logos and other media resources are available at Lung.org/media